Cephalon Inc. said Wednesday that it intends to hire a 20-person salesforce that will start selling Bristol-Myers Squibb Co.'s Stadol NS to theneurology market later this year. The Aug. 3 edition of BioWorldToday said Cephalon had already assembled its sales force.

(c) 1997 American Health Consultants. All rights reserved.

No Comments